By Josh White
Date: Wednesday 22 May 2024
LONDON (ShareCast) - (Sharecast News) - Asthma-focussed medical device company Niox said in an update on Wednesday that it continued to perform strongly in the year to date, meeting management expectations.
The AIM-traded firm, which was holding its annual general meeting, noted that it settled returns claims totaling £0.4m in January, related to its discontinued business operations.
As of 30 April, the unaudited cash balance for Niox was £23.7m, up from £19.9m at the end of December 2023, with the company maintaining a debt-free status.
Niox said it would provide a trading update for the six months ending 30 June in mid-July.
At 1240 BST, shares in Niox Group were up 1.1% at 73.4p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 63.80p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 76.00 |
52 Week Low | 54.60 |
Volume | 0 |
Shares Issued | 399.36m |
Market Cap | £254.79m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 3 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 15-May-25 | 23-May-24 |
Paid | 16-Jun-25 | 24-Jun-24 |
Amount | 1.25p | 1.00p |
You are here: research